METHODS	Plasma samples at delivery and during days 8 to 45 postpartum were obtained from HIV-infected Thai women who received an intrapartum NVP dose in the Perinatal HIV Prevention Clinical Trial-2 ( PHPT-2 ) for the prevention of perinatal HIV transmission .\